| 晚期非小细胞肺癌靶向治疗的研究进展 |
| |
| 引用本文： | 刘友如,姜丽岩.晚期非小细胞肺癌靶向治疗的研究进展[J].药学服务与研究,2012(3):166-171. |
| |
| 作者姓名： | 刘友如 姜丽岩 |
| |
| 作者单位： | 上海交通大学医学院附属胸科医院肺内科,上海200030 |
| |
| 摘 要： | 近年来,以表皮生长因子受体酪氨酸激酶抑制剂为代表的晚期非小细胞肺癌靶向治疗取得实质性进展。靶向治疗在提高病人生存率、改善生活质量方面有重要的作用。晚期非小细胞肺癌靶向治疗的靶点、药物和相关研究正以多元化的形式不断推陈出新,本文将简要综述当前晚期非小细胞肺癌靶向治疗的重大研究进展。
|
| 关 键 词： | 非小细胞肺癌 靶向治疗 综述 |
Advances in research on targeted therapy of advanced non-small-cell lung cancer |
| |
| LIU YouRu,JIANG LiYan.Advances in research on targeted therapy of advanced non-small-cell lung cancer[J].Pharmaceutical Care and Research,2012(3):166-171. |
| |
| Authors: | LIU YouRu JIANG LiYan |
| |
| Institution: | (Department of Pulmonary Diseases, Chest Hospital affiliated to School of Medicine, Shanghai Jiaotong University, Shanghai 200030,China) |
| |
| Abstract: | Recently, as a representative of targeted therapy, epidermal growth {actor receptor-tyrosine kinase inhibitors （EGFR-TKIs） in advanced non-small-cell lung cancer （NSCLC） have made substantial progress. Targeted therapy has important roles in improving survival rate and quality of life of the patients. Targets, drugs and related researches of targeted therapy in NSCLC are innovating in diversified forms. Current major research progress of targeted therapy in NSCLC will be briefly reviewed in the article. |
| |
| Keywords: | non-small-cell lung cancer targeted therapy review |
| 本文献已被 CNKI 维普 等数据库收录！ |
